Cargando…
Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study
Background: Actinic keratosis (AK) is a cutaneous lesion resulting from the proliferation of atypical epidermal keratinocytes caused by long-term exposure to ultraviolet radiation. AK may progress to cutaneous squamous cell carcinoma (cSCC) and therefore is often treated with topical agents such as...
Autores principales: | Kirchberger, Michael Constantin, Gfesser, Michael, Erdmann, Michael, Schliep, Stefan, Berking, Carola, Heppt, Markus Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381110/ https://www.ncbi.nlm.nih.gov/pubmed/37510952 http://dx.doi.org/10.3390/jcm12144837 |
Ejemplares similares
-
Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action
por: Schlesinger, Todd, et al.
Publicado: (2022) -
Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland
por: Dymond, Amy, et al.
Publicado: (2023) -
A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic Keratosis
por: Wessely, Anja, et al.
Publicado: (2021) -
1% Tirbanibulin Ointment for the Treatment of Actinic
Keratoses
por: Dao, Diem-Phuong D., et al.
Publicado: (2021) -
Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
por: Heppt, Markus V., et al.
Publicado: (2022)